RE: thoughts?12 Nov 2020 19:24
Hi Bojo
My first thought was very interesting.
Off the top of my head ODX has a 30% share in contracts that Abingdon wins so, as a company it is not devastating.
ODX has its own ce approved antibody test to hang a hat on.
it also has its Vistect brand products.
So the future?
If there is a mass bailout the price could fall to a bargain basement price
I think ODX's future is secure but it is going to be battered. The big rns holders were hoping for was mhra approval to the uk rtc test and this could now be in jeopardy.
Mologic may manufacture its antigen test leaving ODX out in the cold
Share price is one to watch I think.